Company Filing History:

6 out of 377

Aventis Pharma S.a.

patents

5 out of 247

Rhone-poulenc Rorer S.a.

patents

Years Active: 1999-2009

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7473701 - Substituted indazoles, compositions containing them, method of production and use (2009-01-06),

2. 6858638 - Substituted indazoles, compositions containing them, method of production and use (2005-02-22),

3. 6713468 - Methods of using thiazolobenzoheterocycles (2004-03-30),

4. 6448241 - Thiazolobenzoheterocycles, their preparation and medicaments containing them (2002-09-10),

5. 6423715 - Thiazolobenzoheterocycles, their preparation and medicaments containing them (2002-07-23),

6. 6369221 - Thiazolobenzoheterocycles, preparation and medicines containing same (2002-04-09),

7. 6288075 - Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same (2001-09-11),

8. 6100264 - 5H, 10H-imidazo [1,2-A] indeno [1,2-E] pyrazin-4-one derivatives, their (2000-08-08),

9. 6057454 - 1-oxo-1H-inden-2-yl-1H-imidazole-2-carboxylic acid intermediates (2000-05-02),

10. 5990108 - 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives, (1999-11-23),

11. 5902803 - 5H,10H-imidazo�1,2-a!indeno�1,2-e!pyrazin-4-one derivatives, preparation (1999-05-11),

Title: Patrick Nemecek: Innovator in Kinase-Inhibiting Compounds

Introduction

Patrick Nemecek is a notable inventor based in Thiais, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase-inhibiting compounds. With a total of 11 patents to his name, Nemecek's work has had a considerable impact on therapeutic applications, especially in oncology.

Latest Patents

Among his latest patents, Nemecek has focused on "Substituted indazoles, compositions containing them, method of production and use." This invention relates to novel specific substituted indazoles that exhibit kinase-inhibiting activity. These compounds have therapeutic potential, particularly in the treatment of cancer. The innovative methods of production and use outlined in his patents highlight the importance of these compounds in modern medicine.

Career Highlights

Throughout his career, Patrick Nemecek has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Aventis Pharma S.A. and Rhône-Poulenc Rorer S.A. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Nemecek has collaborated with several esteemed professionals in his field, including Jean-Claude Hardy and Jean-Claude Aloup. These partnerships have likely enhanced his research and development efforts, leading to successful innovations.

Conclusion

Patrick Nemecek's contributions to the field of pharmaceuticals, particularly through his patents on kinase-inhibiting compounds, demonstrate his commitment to advancing medical science. His work continues to influence therapeutic strategies in oncology, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.